Actavis Holdco US, Inc.
Records under this name other than the patents Actavis Holdco US, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Actavis Holdco US, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,785,627 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Term ended Term ended Jul 31, 2026 · USPTO record | Term ended | Term ended Jul 31, 2026 | USPTO record |
| US 8,470,368 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Term ended Term ended Nov 1, 2023 · USPTO record | Term ended | Term ended Nov 1, 2023 | USPTO record |
| US 8,309,125 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Term ended Ended no later than Sep 19, 2023 · USPTO record | Term ended | Ended no later than Sep 19, 2023 | USPTO record |
| US 8,668,931 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Term ended Ended no later than Sep 19, 2023 · USPTO record | Term ended | Ended no later than Sep 19, 2023 | USPTO record |
| US 6,630,166 | Compositions for conjugated estrogens and associated methods Term ended Term ended Feb 12, 2022 · USPTO record | Term ended | Term ended Feb 12, 2022 | USPTO record |
| US 8,597,683 | Modified release tranexamic acid formulation Lapsed on the fee record Ended Dec 3, 2021 · USPTO record | Lapsed on the fee record | Ended Dec 3, 2021 | USPTO record |
| US 9,387,178 | Modified release tranexamic acid formulation Lapsed on the fee record Ended Jul 12, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 12, 2020 | USPTO record |
| US 6,180,133 | Antioxidant composition for topical/transdermal prevention and treatment of wrinkles Term ended Term ended Nov 24, 2018 · USPTO record | Term ended | Term ended Nov 24, 2018 | USPTO record |
| US 8,309,104 | Oral controlled release formulation for sedative and hypnotic agents Lapsed on the fee record Ended Nov 13, 2016 · USPTO record | Lapsed on the fee record | Ended Nov 13, 2016 | USPTO record |
| US D440,650 | Tablet Term ended Term ended Apr 17, 2015 · USPTO record | Term ended | Term ended Apr 17, 2015 | USPTO record |